Mechanisms linking osteoporosis with cardiovascular calcification

Current Osteoporosis Reports

Volumn 7, Issue 2, 2009, Pages 42-46

  Demer, Linda L ^a   Tintut, Yin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CYSTEINE PROTEINASE INHIBITOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTOR ALPHA;

AORTA DISEASE; ARTERY CALCIFICATION; BLOOD VESSEL CALCIFICATION; BONE MATRIX; BONE MINERALIZATION; CALCIUM METABOLISM; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME INHIBITION; ENZYME REGULATION; EXERCISE; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; OSTEOBLAST; OSTEOPHYTE; OSTEOPOROSIS; PATHOGENESIS; REVIEW; TISSUE REPAIR; TISSUE SPECIFICITY; VASCULAR SMOOTH MUSCLE;

AGING; ALPHA-FETOPROTEINS; ATHEROSCLEROSIS; CALCINOSIS; CARDIOVASCULAR DISEASES; HUMANS; MOTOR ACTIVITY; OSTEOPOROSIS;

EID: 70349756976     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-009-0008-1     Document Type: Review

References (46)

1. Towler DA: Vascular calcifAcation in ESRD: another cloud appears in the perfect storm - but highlights a silver lining? Kidney Int 2004, 66:2467-2468.
2. Vattikuti R, Towler DA: Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 2004, 286:E686-E696.
3. Schousboe JT, Taylor BC, Kiel DP, et al.: Abdominal aortic calcification detected on lateral spine images from a bone densitometer predicts incident myocardial infarction or stroke in older women. J Bone Miner Res 2008, 23:409-416.
4. Guzman RJ: Clinical, cellular, and molecular aspects of arterial calcification. J Vasc Surg 2007, 45:A57-A63.
5. Huang H, Virmani R, Younis H, et al.: The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation 2001, 103:1051-1056.
6. Bluestein D, Alemu Y, Avrahami I, et al.: Influence of microcalcifications on vulnerable plaque mechanics using FSI modeling. J Biomech 2008, 41:1111-1118.
7. Lin TC, Tintut Y, Lyman A, et al.: Mechanical response of a calcified plaque model to fluid shear force. Ann Biomed Eng 2006, 34:1535-1541.
8. Chen NX, O'Neill KD, Chen X, Moe SM: Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res 2008, 23:1798-1805.
9. Duer MJ, Friscic T, Proudfoot D, et al.: Mineral surface in calcified plaque is like that of bone: Further evidence for regulated mineralization. Arterioscler Thromb Vasc Biol 2008, 28:2030-2034.
10. Toussaint ND, Lau KK, Strauss BJ, et al.: Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 2008, 23:586-593.
11. Bagger YZ, Tanko LB, Alexandersen P, et al.: Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 2006, 259:598-605.
12. Tekin GO, Kekilli E, Yagmur J, et al.: Evaluation of cardiovascular risk factors and bone mineral density in post menopausal women undergoing coronary angiography. Int J Cardiol 2008, 131:66-69.
13. Farhat GN, Cauley JA, Matthews KA, et al.: Volumetric BMD and vascular calcification in middle-aged women: The Study of Women's Health Across the Nation. J Bone Miner Res 2006, 21:1839-1846.
14. Shen H, Bielak LF, Streeten EA, et al.: Relationship between vascular calcification and bone mineral density in the Old-order Amish. Calcif Tissue Int 2007, 80:244-250.
15. Sinnott B, Syed I, Sevrukov A, Barengolts E: Coronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with aging. Calcif Tissue Int 2006, 78:195-202.
16. Adragao T, Branco P, Birne R, et al.: Bone mineral density, vascular calcifications, and arterial stiffness in peritoneal dialysis patients. Perit Dial Int 2008, 28:668-672.
17. Al-Aly Z, Shao JS, Lai CF, et al.: Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol 2007, 27:2589-2596.
18. Cheng SL, Shao JS, Cai J, et al.: Msx2 exerts bone anabolism via canonical Wnt signaling. J Biol Chem 2008, 283:20505-20522.
19. Lai CF, Seshadri V, Huang K, et al.: An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells. Circ Res 2006, 98:1479-1489.
20. Aikawa E, Nahrendorf M, Figueiredo JL, et al.: Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007, 116:2841-2850.
21. Tintut Y, Morony S, Demer LL: Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol 2004, 24:e6-e10.
22. Brodeur MR, Brissette L, Falstrault L, et al.: Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells. Free Radic Biol Med 2008, 44:506-517.
23. Hirasawa H, Tanaka S, Sakai A, et al.: ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells. J Bone Miner Res 2007, 22:1020-1030.
24. Huang MS, Morony S, Lu J, et al.: Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts. J Biol Chem 2007, 282:21237-21243.
25. Huang MS, Lu J, Ivanov Y, et al.: Hyperlipidemia impairs osteoanabolic effects of PTH. J Bone Miner Res 2008, 23:1672-1679.
26. Sebastian EM, Suva LJ, Friedman PA: Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renal failure. Bone 2008, 43:1022-1030.
27. Shao JS, Cheng SL, Charlton-Kachigian N, et al.: Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice. J Biol Chem 2003, 278:50195-50202.
28. Bagger YZ, Rasmussen HB, Alexandersen P, et al.: Links between cardiovascular disease and osteoporosis in postmenopausal women: Serum lipids or atherosclerosis per se? Osteoporos Int 2007, 18:505-512.
29. Al-Jallad HF, Nakano Y, Chen JL, et al.: Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures. Matrix Biol 2006, 25:135-148.
30. Johnson KA, Polewski M, Terkeltaub RA: Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ Res 2008, 102:529-537.
31. Mikami S, Hamano T, Fujii N, et al.: Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients. Hypertens Res 2008, 31:1163-1170.
32. Frost ML, Grella R, Millasseau SC, et al.: Relationship of calcification of atherosclerotic plaque and arterial stiffness to bone mineral density and osteoprotegerin in postmenopausal women referred for osteoporosis screening. Calcif Tissue Int 2008, 83:112-120.
33. Bucay N, Sarosi I, Dunstan CR, et al.: Osteoprotegerindeficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998, 12:1260-1268.
34. Bennett BJ, Scatena M, Kirk EA, et al.: Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice. Arterioscler Thromb Vasc Biol 2006, 26:2117-2124.
35. Morony S, Tintut Y, Zhang Z, et al.: Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation 2008, 117:411-420.
36. Orita Y, Yamamoto H, Kohno N, et al.: Role of osteoprotegerin in arterial calcification: Development of new animal model. Arterioscler Thromb Vasc Biol 2007, 27:2058-2064.
37. Hofbauer LC, Schrader J, Niebergall U, et al.: Interleukin-4 differentially regulates osteoprotegerin expression and induces calcification in vascular smooth muscle cells. Thromb Haemost 2006, 95:708-714.
38. Bakhireva LN, Laughlin GA, Bettencourt R, Barrett-Connor E: Does osteoprotegerin or receptor activator of nuclear factor-kappaB ligand mediate the association between bone and coronary artery calcification? J Clin Endocrinol Metab 2008, 93:2009-2012.
39. Fiore CE, Celotta G, Politi GG, et al.: Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass. Atherosclerosis 2007, 195:110-115.
40. Karasik D, Kiel DP, Kiely DK, et al.: Abdominal aortic calcification and exostoses at the hand and lumbar spine: The Framingham Study. Calcif Tissue Int 2006, 78:1-8.
41. Price PA, Chan WS, Jolson DM, Williamson MK: The elastic lamellae of devitalized arteries calcify when incubated in serum: Evidence for a serum calcification factor. Arterioscler Thromb Vasc Biol 2006, 26:1079-1085.
42. Price PA, Roublick AM, Williamson MK: Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 2006, 70:1577-1583.
43. Tamagaki K, Yuan Q, Ohkawa H, et al.: Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia. Nephrol Dial Transplant 2006, 21:651-659.
44. Wilund KR, Tomayko EJ, Evans EM, et al.: Physical activity, coronary artery calcium, and bone mineral density in elderly men and women: A preliminary investigation. Metabolism 2008, 57:584-591.
45. Lee CD, Jacobs DR Jr, Hankinson A, et al.: Cardiorespiratory fitness and coronary artery calcification in young adults: The CARDIA Study. Atherosclerosis 2009, 203:263-268.
46. Adami S, Gatti D, Viapiana O, et al.: Physical activity and bone turnover markers: A cross-sectional and a longitudinal study. Calcif Tissue Int 2008, 83:388-392.